RESPONSINF stock news
This page provides real-time market news, earnings updates, and company announcements related to Response Informatics Ltd (RESPONSINF).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-24 18:37 IST
Elon Musk Says 'Nothing To Do' With Amazon's Kuiper As Starlink Moves To Offer Free Hardware: 'Trying To Make Starlink More Affordable…'
Finviz2026-02-24 07:24:48
The 5 Most Interesting Analyst Questions From Genco's Q4 Earnings Call
Finviz2026-02-24 08:45:04
5 Thought-Provoking Analyst Inquiries From Bel Fuse’s Fourth Quarter Earnings Discussion
101 finance2026-02-24 09:06:34
5 Essential Analyst Inquiries from JELD-WEN’s Fourth Quarter Earnings Discussion
101 finance2026-02-24 09:06:34
Medifast’s Fourth Quarter Earnings Conference: The Five Key Questions from Analysts
101 finance2026-02-24 09:06:34
The Top 5 Analyst Inquiries That Stood Out During Allegion’s Q4 Earnings Call
101 finance2026-02-24 09:06:34
5 Thought-Provoking Analyst Inquiries from La-Z-Boy’s Fourth Quarter Earnings Discussion
101 finance2026-02-24 09:06:36
The Top 5 Analyst Questions That Stood Out During Hillman’s Q4 Earnings Call
101 finance2026-02-24 09:06:35
Nvidia Q4 results: Will it drive the AI market to new heights once more?
101 finance2026-02-24 10:03:12
Why Is MacroGenics Stock Sinking Tuesday?
Finviz2026-02-24 11:18:42
Top Gap Ups and Downs on Friday: WMT, ORCL, NVO and More
moomoo-证劵2026-02-24 11:40:08
Elon Musk really took the steering wheel off.
金融界2026-02-24 11:57:20
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
Finviz2026-02-24 12:03:56
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026
Finviz2026-02-24 12:03:57
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 12:03:58
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas
Finviz2026-02-24 12:03:59
Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms
Finviz2026-02-24 12:03:58
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Nokia Partners With AWS To Transform Network Slicing For Telecom Providers
Finviz2026-02-24 12:24:42
Skittish investors spooked as dystopian AI outlooks go viral
101 finance2026-02-24 12:27:16
Protara's Experimental Bladder Cancer Drug Shows Encouraging Results
Finviz2026-02-24 12:45:12
EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia
Finviz2026-02-24 12:54:08
Artelo Biosciences Provides Business Update Highlighting Clinical Progress and Reports Fiscal 2025 Year-End Financial Results
Finviz2026-02-24 13:03:09
Medifast’s Fourth Quarter Earnings Conference: The Five Key Questions from Analysts
101 finance2026-02-24 09:06:34
The Top 5 Analyst Inquiries That Stood Out During Allegion’s Q4 Earnings Call
101 finance2026-02-24 09:06:34
5 Thought-Provoking Analyst Inquiries from La-Z-Boy’s Fourth Quarter Earnings Discussion
101 finance2026-02-24 09:06:36
The Top 5 Analyst Questions That Stood Out During Hillman’s Q4 Earnings Call
101 finance2026-02-24 09:06:35
Nvidia Q4 results: Will it drive the AI market to new heights once more?
101 finance2026-02-24 10:03:12
Why Is MacroGenics Stock Sinking Tuesday?
Finviz2026-02-24 11:18:42
Top Gap Ups and Downs on Friday: WMT, ORCL, NVO and More
moomoo-证劵2026-02-24 11:40:08
Elon Musk really took the steering wheel off.
金融界2026-02-24 11:57:20
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
Finviz2026-02-24 12:03:56
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026
Finviz2026-02-24 12:03:57
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 12:03:58
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas
Finviz2026-02-24 12:03:59
Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms
Finviz2026-02-24 12:03:58
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Nokia Partners With AWS To Transform Network Slicing For Telecom Providers
Finviz2026-02-24 12:24:42
Skittish investors spooked as dystopian AI outlooks go viral
101 finance2026-02-24 12:27:16
Protara's Experimental Bladder Cancer Drug Shows Encouraging Results
Finviz2026-02-24 12:45:12
EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia
Finviz2026-02-24 12:54:08
Artelo Biosciences Provides Business Update Highlighting Clinical Progress and Reports Fiscal 2025 Year-End Financial Results
Finviz2026-02-24 13:03:09
RESPONSINF stock price change
On the last trading day, RESPONSINF stock closed at 25.85 INR, with a price change of -2.49% for the day.
Trade stock perpsRESPONSINF stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more